A multi-center, multi-year registry of patients with gastroesophageal reflux disease (GERD) undergoing diagnostic evaluation and/or treatment of GERD and associated diseases and complications.
This registry is a prospective, multicenter registry of patients undergoing diagnostic evaluation and/or treatment of gastroesophageal reflux disease and associated diseases and complications. Patients who are eligible will have disease and therapy-specific data collected throughout treatment and long-term (5-year) follow-up. Electronic data capture via REDCap will be utilized for all sites.
Study Type
OBSERVATIONAL
Enrollment
2,000
UCI-Irvine
Orange, California, United States
Johns Hopkins Hospital
Baltimore, Maryland, United States
Mayo Clinic
Rochester, Minnesota, United States
UNRMed-University of Nevada, Reno
Reno, Nevada, United States
Demographic and clinical data obtained via chart review and questionnaires
Establish a registry with collected data related to patients undergoing diagnostic evaluation and treatment of GERD and its associated diseases in multiple academic and community settings.
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Weill Cornell
New York, New York, United States
Geisinger
Danville, Pennsylvania, United States
The Matagorda Regional Medical Group
Bay City, Texas, United States
UT Health
Houston, Texas, United States
Fox Valley Surgical Associates
Appleton, Wisconsin, United States